Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-01-10 @ 2:26 PM
Study NCT ID:
NCT03294304
Status:
COMPLETED
Last Update Posted:
2021-12-16
First Post:
2017-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-22
First Submit QC Date:
None
Study First Post Date:
2017-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-03
Results First Submit QC Date:
None
Results First Post Date:
2021-12-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-18
Last Update Post Date:
2021-12-16
Last Update Post Date Type:
ACTUAL